Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Radioimmunotherapy
Jun 20, 2019
Actinium's Portfolio of Antibody Radiation-Conjugates to be Highlighted in Two Oral and Two Poster Presentations at the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
May 21, 2019
Nordic Nanovector: Archer-1 Phase 1b Betalutin®/Rituximab Combination Trial Advances to Next Cohort
Jan 04, 2019
MabVax Therapeutics and Oncotelic Enter into Merger Discussions
Nov 14, 2018
Radimmune Therapeutics Selected Goodwin Biotechnology for Process Development through cGMP Manufacturing of their IgG Monoclonal Antibody and Conjugate
Apr 30, 2018
MabVax Therapeutics to Present an Interactive Live Webcast at VirtualInvestorConferences.com
Apr 13, 2018
MabVax Therapeutics Receives Continued Listing Deficiency Notice for Nasdaq's Minimum Stockholders' Equity Requirements
Apr 02, 2018
MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones
Feb 07, 2018
MabVax to Present at BIO CEO & Investor Conference
Dec 13, 2017
MabVax Therapeutics Announces Completion of Enrollment and Dosing in Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers
Nov 13, 2017
MabVax Therapeutics to Present Positive Development Study Results Enabling Manufacturing of Two Radionuclide Products for Phase 1 Clinical Trials at the 2017 AAPS Annual Meeting
Oct 24, 2017
MabVax Therapeutics Expands Intellectual Property Estate by Filing a New Patent Application on its Fully-Human Antibody Discoveries
Oct 17, 2017
MabVax Therapeutics Holdings, Inc. Provides Corporate Overview and Business Outlook
Oct 11, 2017
MabVax Therapeutics Initiates Patient Enrollment in a Phase 1 Trial for MVT-1075, a New Radioimmunotherapy Treatment for Advanced Pancreatic, Colon and Lung Cancers
Oct 06, 2017
MabVax Stockholders Approve Remaining Proposal at Special Meeting of Stockholders
Sep 22, 2017
MabVax Therapeutics Holdings, Inc. Announces $1.25 Million Registered Direct Offering
Sep 13, 2017
MabVax Therapeutics' HuMab-5B1 Antibody to be Featured in Presentations at the 2017 World Molecular Imaging Congress
Sep 12, 2017
MabVax Therapeutics Holdings, Inc. Announces $2.0 Million Registered Direct Offering
Sep 07, 2017
MabVax Therapeutics Holdings, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City
Sep 06, 2017
MabVax Therapeutics Engages Greenhill & Co. as Advisor for Exploring Strategic Alternatives
Jul 24, 2017
MabVax Therapeutics Board of Directors Authorizes the Company to Explore Strategic Alternatives
Page 1
››
Latest News
Apr 19, 2024
Construction Equipment Global Strategic Business Report 2024: Market to Reach $248.5 Billion by 2030 - Focus...
Apr 19, 2024
New Jersey Natural Gas to Reduce Fleet Emissions with Neste MY Renewable Diesel
Apr 19, 2024
VulnCheck Closes $7.95 Million in Seed Funding to Accelerate Momentum Amid Growing Demand for its Next-...
Apr 19, 2024
AEVEX Aerospace to Debut Atlas Loitering Munition at 2024 Army Aviation Mission Solutions Summit
Apr 19, 2024
Solar Sector Sees $8.1 Billion in Corporate Funding in Q1 2024, Reports Mercom Capital Group
Apr 19, 2024
US Consumers’ 2024 Sustainability Score Declines and Lags the Global Average, According to New Report
Apr 19, 2024
Kontoor Brands Declares Quarterly Dividend
Apr 19, 2024
American Water Honored as a 2024 VETS Indexes 5 Star Employer
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events